Khalil Zaman

Lausanne Branch
Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Journal: JAMA oncology
Published: December 18, 2025

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Journal: Oncology
Published: November 27, 2025

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Journal: JAMA network open
Published: November 03, 2025

Breast cancer screening in Switzerland : organised, opportunistic, or opting out ?

Breast cancer screening in Switzerland : organised, opportunistic, or opting out ?

Journal: Revue medicale suisse
Published: October 30, 2025

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.

Journal: JACC. CardioOncology
Published: September 04, 2025

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Journal: Cancer research
Published: August 06, 2025

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Journal: Cancer research
Published: August 06, 2025

Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2025

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study).

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study).

Journal: Journal of cancer research and clinical oncology
Published: April 25, 2025

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

Journal: Nature medicine
Published: March 12, 2025

Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02.

Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 12, 2025

The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial.

The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial.

Journal: Psycho-oncology
Published: March 06, 2025
Showing 1-12 of 134

Last Updated: 09/26/2026